Inventor · Hamilton, MA, US

David Fabrizio

22Patents
8h-index
53Co-inventors
74Inventor score

Filing activity: Nov 21, 2007 → Feb 2, 2022

Most-cited inventions

PatentTitleAreaCited byStatus
US8969289B2 Serum albumin binding molecules Chemistry; Metallurgy 40 Active
US8524244B2 Targeted therapeutics based on engineered proteins that bind EGFR Chemistry; Metallurgy 40 Active
US8470332B2 Targeted therapeutics based on engineered proteins for tyrosine kinases receptors, including IGF-IR Chemistry; Metallurgy 39 Active
US9234028B2 Targeted therapeutics based on engineered proteins that bind EGFR Chemistry; Metallurgy 28 Active
US9540424B2 Serum albumin binding molecules Chemistry; Metallurgy 26 Active
US9920108B2 Targeted therapeutics based on engineered proteins that bind EGFR Chemistry; Metallurgy 19 Active
US10406251B2 PD-L1 binding polypeptides for imaging Physics 14 Active
US10221438B2 Serum albumin binding molecules Chemistry; Metallurgy 10 Active
US10221232B2 Methods of treating cancer by administering IGF-IR binding molecules Chemistry; Metallurgy 7 Active
US10442851B2 Serum albumin-binding fibronectin type III domains Chemistry; Metallurgy 3 Active
US11279767B2 Therapeutic and diagnostic methods for cancer Emerging Cross-Sectional Technologies 3 Active
US11344639B2 PET imaging with PD-L1 binding polypeptides Chemistry; Metallurgy 3 Active
US10781247B2 Targeted therapeutics based on engineered proteins that bind EGFR Chemistry; Metallurgy 3 Active
US11173219B2 PD-L1 binding polypeptides for imaging Physics 3 Active
US10934572B2 Serum albumin binding molecules Chemistry; Metallurgy 2 Active
US11300570B2 Therapeutic and diagnostic methods for cancer Emerging Cross-Sectional Technologies 2 Active
US11149077B2 Targeted therapeutics based on engineered proteins for tyrosine kinases receptors, including IGF-IR Chemistry; Metallurgy 1 Active
US11203630B2 Serum albumin-binding fibronectin type III domains Chemistry; Metallurgy 0 Active
US12194110B2 PD-L1 binding polypeptides for imaging Physics 0 Active
US11674962B2 Therapeutic and diagnostic methods for cancer Emerging Cross-Sectional Technologies 0 Active
US12331128B2 Therapeutic and diagnostic methods for cancer Emerging Cross-Sectional Technologies 0 Active
US11725247B2 Methods of treating cancer Emerging Cross-Sectional Technologies 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.